| Prev Close: | 129.16 |
|---|---|
| Open: | 129.94 |
| Bid: | 130.97 x 100 |
| Ask: | 137.82 x 400 |
| NAV¹: | 59.82 |
| Net Assets²: | 953.48M |
| YTD Return (Mkt)²: | 35.79% |
| Day's Range: | 129.36 - 131.83 |
|---|---|
| 52wk Range: | 81.35 - 132.42 |
| Volume: | 240,278 |
| Avg Vol (3m): | 259,420 |
| P/E (ttm)²: | 28 |
| Yield (ttm)²: |
¹As of Nov 29, 2012
²As of Aug 30, 2013
Headlines
- Monday's ETF Movers: PFF, XBIat Forbes(Mon, Sep 30)
- Knowing When To Be An Optimist, A Dreamer, Or A Realist In Biotech Investing Can Make All The Differenceat Seeking Alpha(Sat, Sep 28)
- Thursday's ETF Movers: XBI, GDXJat Forbes(Thu, Sep 26)
- Biotech The Equal-Weight WayETF Trends(Wed, Sep 25)
- [video] Will the BlackBerry deal happen?at CNBC(Mon, Sep 23)
- Biotech ETFs: Outstanding Risk-Adjusted Portfoliosat Seeking Alpha(Sun, Sep 22)
- Top Biotech Stock Picks for Q4 2013: An Interview with Boris Peaker, Executive Director and Senior Analyst at Oppenheimer & Co. Inc.Wall Street Transcript(Fri, Sep 13)
- Biotech ETFs Among 2013 Best PerformersIndexUniverse.com(Thu, Sep 12)
- Wednesday's ETF Movers: ITB, XBIat Forbes(Wed, Sep 11)
- The Smartest Way To Play The Booming Biotech Sectorat Seeking Alpha(Tue, Sep 10)
- 3 Lower-Risk Ways to Invest in Health Careat Motley Fool(Fri, Sep 6)
- Smaller Biotech ETF Hangs With The Big BoysETF Trends(Fri, Sep 6)
- A Biotech ETF for Up-and-Coming Drug DevelopersETF Trends(Thu, Sep 5)
- XBI, ALNY, INCY, NPSP: ETF Inflow Alertat Forbes(Wed, Sep 4)
- Three ETFs to Play Up-and-Coming Health Care CompaniesETF Trends(Tue, Sep 3)
Reports
- XBI: Fundamental Valuation and Predictive Rating ReportNew Constructs, LLC(Oct 1)
- Trading Report for (XBI). A detailed report, including free correlated market...Stock Traders Daily(Oct 1)
- The Investment Rate - a measure of investment demand.Stock Traders Daily(Oct 1)
